英矽智能将携四项临床前研究成果，亮相2023年美国癌症研究协会年会 (VIDEO) InSilico Medicine This video is under embargo. Please login to access this video. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Caption 包括两款聚焦“合成致死”策略的在研项目USP1抑制剂ISM3091和MAT2A抑制剂ISM34121、一款具有全球首创潜力的DGKA抑制剂ISM4312A 和首次对外披露的CDK12抑制剂ISM6466A Credit 英矽智能 Usage Restrictions none License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
